1-3 of 3
Mary Ann Stevenson
Close
Sort by
Journal Articles

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation

Clinical Trials & Observations
Shira L. Galper, James B. Yu, Peter M. Mauch, Jon F. Strasser, Barbara Silver, Ann LaCasce, Karen J. Marcus, Mary Ann Stevenson, Ming Hui Chen, Andrea K. Ng
Journal: Blood
Blood (2011) 117 (2): 412–418.
https://doi.org/10.1182/blood-2010-06-291328
Published: 2011
Journal Articles

A Comparative Analysis of Immune Reconstitution Following Reduced Intensity Conditioning with CAMPATH-1H and Total Lymphoid Irradiation/Anti-Thymocyte Globulin Prior to Allogeneic Stem Cell Transplantation.

Brett Glotzbecker, MD, Heidi Mills, BA, Jacalyn Rosenblatt, MD, Zekui Wu, MD, Kerry Wellenstein, Baldev Vasir, PhD, Robin Joyce, MD, James D. Levine, MD, Dimitrios Tzachanis, MD, PhD, Jeffrey Zwicker, M.D., Vassiliki A Boussiotis, MD, PhD, Mary Ann Stevenson, MD, Thomas Spitzer, MD, Carol Delaney, Jessica Bonhoff, BA, Nancy Giallombardo, NP, Katharine Conway, NP, David F. McDermott, MD, David Avigan, MD
Journal: Blood
Blood (2009) 114 (22): 1148.
https://doi.org/10.1182/blood.V114.22.1148.1148
Published: 2009
Journal Articles

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

Clinical Trials & Observations
Andrea K. Ng, M. V. Patricia Bernardo, Edie Weller, Kendall Backstrand, Barbara Silver, Karen C. Marcus, Nancy J. Tarbell, Mary Ann Stevenson, Jonathan W. Friedberg, Peter M. Mauch
Journal: Blood
Blood (2002) 100 (6): 1989–1996.
https://doi.org/10.1182/blood-2002-02-0634
Published: 2002